AI generated
Aug 30, 2026, 12:51
When to Escalate Treatment in Sickle Cell Crisis – ISBT
International Society of Blood Transfusion (ISBT) shared a post on LinkedIn:
“Sickle Cell Crisis: When to Escalate Therapy – Part 2
In part 1, we looked at the clinical red flags that can signal a complicated or organ-threatening sickling crisis. In part 2, we explore when red cell exchange (RCE) should be considered and where PLEX may fit in severe, refractory disease.
Key messages:
- Know when urgent RCE may be indicated.
- Reduce HbS while avoiding hyperviscosity.
- PLEX is not routine first-line therapy.
- Escalate early and involve a multidisciplinary team when severe organ dysfunction persists.
The goal: interrupt sickling, reverse organ injury and prevent irreversible damage.
Stay connected with the ISBT Clinical Transfusion Working Party for more educational content and updates in clinical transfusion.”
See more in the gallery.
Stay updated with Hemostasis Today.
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases
-
Aug 30, 2026, 16:16Fatima Zafar: Anaemia – Why This “Common” Condition Should Never Be Ignored
-
Aug 30, 2026, 16:13Umeshkumar C.: Evaluating Scoring Systems and Biomarkers for DIC in Critically Ill Patients